Ziwei Xu

机构：China Pharmaceutical University, Sanda University · ORCID：0000-0003-3945-7000

发表论文 72 篇 · 总被引 902 次 · h-index 18

代表论文

• Cryoablation is superior to radiofrequency ablation for the treatment of non-small cell lung cancer: A meta-analysis (2023 · Cryobiology · 被引 26)
• Construction of a molecular regulatory network for lipids and volatile flavor in Chinese indigenous and hybrid pig pork through integrating multi-omics analysis (2024 · LWT · 被引 21)
• GPRC5B protects osteoarthritis by regulation of autophagy signaling (2023 · Acta Pharmaceutica Sinica B · 被引 17)
• Mulberry leaf supplementation inhibits skatole deposition by regulating gut microbiota and upregulating liver cytochrome P450 1A1 expression in finishing pigs (2023 · Animal nutrition · 被引 15)
• Clinical Investigation of Tyrosinase Inhibitors: Past, Present, and Future (2025 · Drug Development Research · 被引 13)
• Exogenous activation of the adhesion GPCR ADGRD1/GPR133 protects against bone loss by negatively regulating osteoclastogenesis (2025 · Science Advances · 被引 6)